Tüm alıştırma soruları

Soru 501Soru →

Correlate the following detailed clinical observations of pediatric patients with their most appropriate corresponding developmental milestone threshold or pubertal classification.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Cevabı ve açıklamayı göster

Cevap

The clinical profiles map to 9 months, 24 months, 48 months, and Tanner Stage II, respectively, based on their precise constellation of gross motor, fine motor, language, social, and physical developmental markers.

Developmental assessment requires precise correlation of gross motor, fine motor, language, and social skills to chronological age. At 9 months, infants pull to stand and use an inferior pincer grasp. By 24 months, toddlers run, kick balls, use two-word phrases, and play in parallel. At 48 months, preschoolers can hop, copy squares, and play cooperatively. Tanner Stage II is defined by the initial physical manifestations of puberty, specifically breast budding (thelarche) and early sparse, straight pubic hair.

Adım Adım Çözüm

1

Analyze the infant's motor and social skills (pulling to stand, inferior pincer grasp, separation anxiety) and map them to the 9-month threshold.

Matches 9 months of age.

These precede the 12-month milestones of independent standing and a mature (fine) pincer grasp.

2

Evaluate the toddler's presentation (kicking a ball, two-word phrases, turning pages individually, parallel play) against expected developmental progression.

Matches 24 months of age.

This combination of gross motor, language, and social skills is the definitive hallmark of a 2-year-old child.

3

Assess the preschooler's advanced abilities (hopping, copying a square, cooperative play) to determine the developmental age.

Matches 48 months of age.

Hopping on one foot and copying a square are distinct 4-year-old milestones, differentiating this profile from a 3-year-old (who copies a circle and rides a tricycle) or a 5-year-old (who skips and copies a triangle).

4

Identify the physical pubertal findings (breast buds, sparse straight pubic hair) to classify the Sexual Maturity Rating.

Matches Sexual Maturity Rating (Tanner) Stage II.

These specific signs represent the onset of puberty, distinctly differing from the coarser, darker hair and expanded breast tissue of Tanner Stage III.

Anahtar Kavram

Normal Pediatric Developmental Milestones and Pubertal Staging

Tahmini Süre:1m 30s

Soru 502Soru →

A primary care physician is evaluating several patients in an outpatient clinic. Match each patient's clinical presentation with the most appropriate initial management step.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Cevabı ve açıklamayı göster

Cevap

Match the diabetes presentation with metformin, IBS with low-FODMAP diet, essential hypertension with primary antihypertensives, and hypothyroidism with levothyroxine.

Each clinical vignette provides a classic, straightforward presentation of a very common primary care condition. The first-line management for type 2 diabetes is metformin; for IBS is dietary modification; for uncomplicated hypertension is a thiazide, CCB, or ACE inhibitor; and for primary hypothyroidism is levothyroxine.

Adım Adım Çözüm

1

Analyze the first clinical vignette.

Identify a diagnosis of type 2 diabetes mellitus in a patient without contraindications to metformin.

Establishing the diagnosis dictates the standard first-line therapy (metformin and lifestyle changes).

2

Analyze the second clinical vignette.

Identify a diagnosis of irritable bowel syndrome (IBS) based on the Rome criteria (pain relieved by defecation, altered bowel habits).

Recognizing IBS allows for appropriate conservative and symptom-based management rather than invasive testing.

3

Analyze the third clinical vignette.

Identify uncomplicated essential hypertension.

Guidelines recommend starting with a thiazide, calcium channel blocker, or ACE inhibitor for uncomplicated hypertension.

4

Analyze the fourth clinical vignette.

Identify overt primary hypothyroidism (elevated TSH, low free T4).

The standard of care for primary hypothyroidism is levothyroxine replacement.

Anahtar Kavram

First-line outpatient management of common internal medicine conditions (Type 2 Diabetes Mellitus, IBS, Essential Hypertension, Primary Hypothyroidism).

Tahmini Süre:1m 0s

Soru 503Soru →

Evaluate the following clinical scenarios of patients diagnosed with infective endocarditis. Pair each patient profile with the most appropriate definitive antimicrobial regimen based on current treatment guidelines.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Cevabı ve açıklamayı göster

Cevap

The correct pairings match each specific pathogen and host profile with its guideline-directed antimicrobial therapy: S. gallolyticus is treated with ceftriaxone; early prosthetic valve S. epidermidis requires vancomycin, rifampin, and gentamicin; E. faecalis with high-level aminoglycoside resistance requires ampicillin and ceftriaxone; and Q fever endocarditis is treated with doxycycline and hydroxychloroquine.

Each pairing reflects the guideline-directed medical therapy for specific subtypes of infective endocarditis. Streptococcus gallolyticus, strongly associated with colonic malignancy, is highly susceptible and effectively treated with ceftriaxone monotherapy. Early prosthetic valve endocarditis caused by methicillin-resistant Staphylococcus epidermidis requires a triple regimen of vancomycin, rifampin (vital for biofilm eradication), and gentamicin (for initial synergy). For Enterococcus faecalis with high-level aminoglycoside resistance, the standard synergy with gentamicin is ineffective; therefore, dual beta-lactam therapy using ampicillin and ceftriaxone is utilized to achieve synergistic bactericidal activity via differential penicillin-binding protein saturation. Finally, Coxiella burnetii causes culture-negative endocarditis that requires treatment with doxycycline and hydroxychloroquine; the latter alkalinizes the acidic phagolysosome where the bacteria reside, allowing doxycycline to effectively kill the pathogen.

Adım Adım Çözüm

1

Analyze the first patient with Streptococcus gallolyticus native valve endocarditis.

Identified as a highly penicillin-susceptible streptococcus.

Penicillin G or ceftriaxone monotherapy is the standard of care for highly susceptible streptococcal strains causing native valve endocarditis.

2

Evaluate the second patient with early (less than 2 months) prosthetic valve endocarditis due to methicillin-resistant Staphylococcus epidermidis.

Identified the need for broad-spectrum anti-staphylococcal therapy with biofilm penetration and synergistic coverage.

The standard regimen for staphylococcal prosthetic valve endocarditis includes vancomycin (for methicillin resistance), rifampin (essential for sterilizing biofilms on prosthetic material), and gentamicin (for early synergy).

3

Assess the third patient with Enterococcus faecalis demonstrating high-level aminoglycoside resistance (HLAR).

Determined that standard ampicillin-gentamicin synergy cannot be utilized.

Ampicillin combined with ceftriaxone provides synergistic bactericidal activity through complementary binding of different penicillin-binding proteins (PBPs), overcoming the limitation imposed by HLAR.

4

Review the fourth patient with Coxiella burnetii (Q fever) culture-negative endocarditis.

Identified an intracellular pathogen requiring specialized combination therapy.

Q fever endocarditis requires prolonged therapy with doxycycline and hydroxychloroquine, as hydroxychloroquine raises the pH of the phagolysosome, rendering doxycycline bactericidal in that environment.

Anahtar Kavram

Definitive antimicrobial therapy for infective endocarditis is tailored to the specific pathogen's resistance mechanisms (e.g., HLAR), the presence of prosthetic material requiring biofilm eradication, and whether the organism is intracellular.

Soru 504Soru →

A pediatric clinic is reviewing its protocols for routine well-child visits. Match the following pediatric patients (presenting for routine well-child checks) with the corresponding immunization or developmental screening newly indicated at that specific age according to standard CDC and AAP guidelines.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Cevabı ve açıklamayı göster

Cevap

The 2-month-old matches with the Rotavirus vaccine; the 12-month-old matches with the MMR vaccine; the 18-month-old matches with ASD screening; and the 11-year-old matches with the MenACWY and Tdap booster.

Each age matches its quintessential preventive care milestone: 2 months for starting the primary rotavirus series; 12 months for the initial live-attenuated MMR vaccine; 18 months for standardized ASD screening; and 11 years for the pre-adolescent Tdap booster and meningococcal vaccine.

Adım Adım Çözüm

1

Identify the preventive care milestone for the 2-month-old infant.

The 2-month visit is the start of primary vaccine series like rotavirus, DTaP, Hib, PCV, and IPV.

Rotavirus vaccine is initiated early in infancy, with the first dose given at 2 months of age to prevent severe gastroenteritis.

2

Identify the preventive care milestone for the 12-month-old infant.

The 12-month visit marks the introduction of live-attenuated vaccines (MMR and varicella).

Maternal IgG antibodies decrease significantly by 12 months, making live vaccines safe and effective without interference.

3

Identify the preventive care milestone for the 18-month-old toddler.

The 18-month visit includes formal developmental screening specifically targeting autism spectrum disorder (ASD).

AAP guidelines mandate standardized ASD screening (such as the M-CHAT) specifically at 18 and 24 months of age.

4

Identify the preventive care milestone for the 11-year-old adolescent.

The 11-year visit transitions into adolescent care with boosters and new conjugate vaccines.

MenACWY, Tdap, and HPV vaccines are routinely administered at the 11-12 year pre-adolescent well-child visit.

Anahtar Kavram

Routine childhood immunization schedules and developmental screening timelines.

Soru 505Soru →

Match each constellation of developmental skills observed during a pediatric health assessment with the chronological age at which they are most typically achieved.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Cevabı ve açıklamayı göster

Cevap

The milestones map as follows: independent ambulation and pointing (12 months); climbing stairs with two feet and a 6-block tower (24 months); tricycle and copying a circle (36 months); hopping and copying a cross (48 months).

Each developmental cluster precisely aligns with a specific annual milestone checkup. The 12-month visit focuses on early walking and precise pincer grasp. The 24-month visit looks for 2-word phrases/pronouns and early stair climbing. The 36-month visit introduces tricycle riding and circle copying. The 48-month visit expects hopping on one foot and drawing a cross.

Adım Adım Çözüm

1

Evaluate the first cluster of milestones (ambulation, tip-to-tip grasp, pointing).

These are identified as classic 1-year (12-month) developmental markers.

Establishing the baseline for late infancy motor and social skills.

2

Evaluate the second cluster (stairs with both feet, 6-block tower, pronouns).

These map directly to the expectations for a 2-year-old (24 months).

Differentiating toddler gross and fine motor advancement.

3

Evaluate the third cluster (three-wheeled cycle, copying a circle, age/gender).

These represent key 3-year (36-month) milestones.

Identifying early preschool developmental markers.

4

Evaluate the fourth cluster (hopping, copying a cross, cooperative play).

These are standard benchmarks for a 4-year-old (48 months).

Confirming school-readiness motor and social milestones.

Anahtar Kavram

Normal Growth and Development

Tahmini Süre:1m 0s

Soru 506Soru →

Match the following characteristic peripheral blood smear descriptions to the most likely underlying hematologic diagnosis.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Cevabı ve açıklamayı göster

Cevap

Smudge cells correspond to Chronic lymphocytic leukemia; bite cells and Heinz bodies correspond to Glucose-6-phosphate dehydrogenase deficiency; schistocytes correspond to Thrombotic thrombocytopenic purpura; and hypersegmented neutrophils correspond to Vitamin B12 deficiency.

Correctly matching the morphological descriptions requires applying the underlying pathophysiology to its visual manifestation: fragile cell membranes in leukemia result in smudge cells, oxidative damage in enzyme deficiency forms Heinz bodies and bite cells, mechanical shearing in small vessels generates schistocytes, and delayed DNA replication in nutritional deficiency leads to hypersegmented nuclear structures.

Adım Adım Çözüm

1

Evaluate the first description highlighting smudge cells and mature-appearing lymphocytes.

Identify the condition as Chronic lymphocytic leukemia.

Neoplastic cells in this leukemia are structurally fragile and easily disrupted mechanically on a glass slide.

2

Evaluate the second description highlighting bite cells and Heinz bodies.

Identify the condition as Glucose-6-phosphate dehydrogenase deficiency.

The absence of normal oxidative defense mechanisms causes hemoglobin denaturation, leading to typical inclusion bodies that are removed by the spleen.

3

Evaluate the third description highlighting schistocytes and profound thrombocytopenia.

Identify the condition as Thrombotic thrombocytopenic purpura.

Systemic microthrombi cause both mechanical damage to red blood cells (forming schistocytes) and consumption of platelets.

4

Evaluate the fourth description highlighting macroovalocytes and hypersegmented neutrophils.

Identify the condition as Vitamin B12 deficiency.

Disrupted cell division and delayed nuclear maturation across hematopoietic cell lines cause distinctive megaloblastic morphological changes.

Anahtar Kavram

Recognizing specific pathognomonic peripheral blood smear findings is highly effective in differentiating among various leukemias, enzymatic defects, microangiopathic processes, and nutritional deficiencies.

Soru 507Soru →

Match each clinical scenario of severe or life-threatening bleeding to the most appropriate specific pharmacological reversal agent.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Cevabı ve açıklamayı göster

Cevap

Unfractionated heparin is reversed by protamine sulfate. Warfarin is reversed by prothrombin complex concentrate. Direct thrombin inhibitors (like dabigatran) are reversed by idarucizumab. Direct factor Xa inhibitors (like rivaroxaban) are reversed by andexanet alfa.

Each distinct class of anticoagulant medication interrupts the coagulation cascade via a unique mechanism, and therefore requires a highly specific antidote to quickly restore hemostasis in the setting of severe or life-threatening hemorrhage.

Adım Adım Çözüm

1

Identify the specific anticoagulant medication or medication class used in each clinical scenario.

Scenario 1 involves unfractionated heparin; Scenario 2 involves a vitamin K antagonist (warfarin, implied by the elevated INR); Scenario 3 involves a direct thrombin inhibitor; Scenario 4 involves a direct factor Xa inhibitor.

Accurate identification of the anticoagulant is required to select the targeted reversal agent.

2

Match the identified anticoagulant with its specific pharmacologic reversal agent for severe bleeding.

Heparin pairs with protamine sulfate; warfarin pairs with prothrombin complex concentrate; direct thrombin inhibitors pair with idarucizumab; direct factor Xa inhibitors pair with andexanet alfa.

Each anticoagulant targets a distinct component of the coagulation cascade, necessitating a unique mechanism of reversal.

Anahtar Kavram

Pharmacologic Reversal of Anticoagulants

Tahmini Süre:1m 0s

Soru 508Soru →

Match each biologic disease-modifying antirheumatic drug (bDMARD) with its specific mechanism of action and the most characteristic clinical caveat or adverse effect associated with its use.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Cevabı ve açıklamayı göster

Cevap

Rituximab depletes CD20 and risks HBV reactivation; Tocilizumab inhibits IL-6 and risks GI perforation; Abatacept blocks CD80/86 and risks COPD exacerbation; Anakinra inhibits IL-1 and requires daily injections; Secukinumab neutralizes IL-17A and risks IBD exacerbation.

Each biologic DMARD has a distinct mechanism of action and a unique adverse effect profile that dictates pre-treatment screening and patient selection. Rituximab (anti-CD20) risks HBV reactivation. Tocilizumab (anti-IL-6R) is associated with dyslipidemia and GI perforations. Abatacept (CTLA-4-Ig) can exacerbate COPD. Anakinra (IL-1RA) has a short half-life requiring daily dosing. Secukinumab (anti-IL-17A) can precipitate or worsen inflammatory bowel disease.

Adım Adım Çözüm

1

Analyze the mechanism and adverse effects of Rituximab.

Rituximab targets CD20 on B cells. A classic and severe complication is hepatitis B reactivation, necessitating prior screening.

Identifying the target and its black-box warnings isolates the correct match.

2

Analyze the mechanism and adverse effects of Tocilizumab.

Tocilizumab targets the IL-6 receptor. It is uniquely associated with dyslipidemia and an increased risk of lower GI perforation, particularly in patients with diverticular disease.

IL-6 blockade has distinct metabolic and tissue-healing effects.

3

Analyze the mechanism and adverse effects of Abatacept.

Abatacept blocks T-cell costimulation via CD80/86. It has a specific warning for use in patients with underlying COPD due to increased respiratory exacerbations.

Costimulation blockade has specific pulmonary caveats.

4

Analyze the mechanism and adverse effects of Anakinra.

Anakinra is an IL-1 receptor antagonist. Its recombinant protein structure gives it a short half-life, requiring daily dosing.

Dosing frequency is a unique clinical caveat among biologics.

5

Analyze the mechanism and adverse effects of Secukinumab.

Secukinumab targets IL-17A. Because IL-17 maintains gut mucosal integrity, its blockade can induce or worsen Crohn disease and ulcerative colitis.

Understanding the physiological role of IL-17 explains its contraindication in IBD.

Anahtar Kavram

The mechanisms of action and highly specific adverse effect profiles of biologic disease-modifying antirheumatic drugs (bDMARDs).

Soru 509Soru →

Correlate each complex clinical scenario with the specific autoantibody marker that best corresponds to the patient's underlying rheumatologic diagnosis.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Cevabı ve açıklamayı göster

Cevap

The correct mappings associate immune-mediated necrotizing myopathy with anti-SRP, scleroderma renal crisis with anti-RNA polymerase III, Mixed Connective Tissue Disease with anti-U1-RNP, and antisynthetase syndrome with anti-Jo-1 antibodies.

Each autoantibody represents a distinct pathophysiologic entity within the rheumatologic spectrum. Anti-SRP mediates aggressive necrotizing myopathy. Anti-RNA polymerase III correlates with rapidly progressive diffuse systemic sclerosis and scleroderma renal crisis. Anti-U1-RNP defines Mixed Connective Tissue Disease with a high risk of pulmonary arterial hypertension. Anti-Jo-1 defines antisynthetase syndrome characterized by myositis, interstitial lung disease, and mechanic's hands.

Adım Adım Çözüm

1

Analyze the first clinical presentation featuring massive CK elevation and necrotizing biopsy without inflammation.

Identified as immune-mediated necrotizing myopathy.

Differentiates this aggressive pathology from classic polymyositis, which typically features prominent CD8+ T-cell endomysial inflammation.

2

Evaluate the patient with diffuse skin thickening and malignant hypertension.

Identified as diffuse cutaneous systemic sclerosis complicated by scleroderma renal crisis.

Requires recognition of the specific autoantibody (anti-RNA polymerase III) conveying the highest risk for this life-threatening renal complication.

3

Assess the presentation of puffy fingers, Raynaud's, and isolated pulmonary arterial hypertension.

Identified as Mixed Connective Tissue Disease (MCTD).

The lack of parenchymal lung disease combined with these specific overlapping connective tissue features points to MCTD rather than pure systemic sclerosis.

4

Review the triad of proximal weakness, interstitial lung disease, and hyperkeratotic fingers.

Identified as antisynthetase syndrome.

The skin findings represent 'mechanic's hands', which alongside ILD and myopathy, are pathognomonic for this specific overlap syndrome driven by anti-Jo-1.

Anahtar Kavram

Advanced serologic profiling in systemic autoimmune diseases, specifically differentiating unique autoantibodies in inflammatory myopathies and scleroderma-spectrum disorders.

Tahmini Süre:2m 30s

Soru 510Soru →

A pediatric clinic evaluates several patients presenting for routine health maintenance or parent concerns regarding growth and development. Match each patient's clinical presentation with the most accurate clinical interpretation and next best step in management.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Cevabı ve açıklamayı göster

Cevap

Patient 1 corresponds to normal corrected development; Patient 2 corresponds to autism red flags; Patient 3 corresponds to normal shifting to genetic potential; Patient 4 corresponds to inadequate caloric intake; Patient 5 corresponds to isolated premature thelarche.

Each vignette represents a highly specific presentation requiring synthesis of distinct developmental and growth principles. Adjusting the premature infant's age from 9 months to 6 months normalizes his milestones. The 16-month-old's isolated lack of pointing indicates a deficit in joint attention, a hallmark of autism. The 24-month-old's growth curve stabilizing at the mid-parental height reflects normal genetic variance. The 14-month-old's weight-only drop is the classic signature of malnutrition. The 7-year-old's normal bone age confirms her thelarche is an isolated, benign variant.

Adım Adım Çözüm

1

Analyze the 9-month-old premature boy.

Calculated corrected age is 6 months. Milestones presented perfectly match 6-month norms, excluding developmental delay.

Premature infants must have their developmental milestones assessed based on their corrected age until they reach 24 months.

2

Evaluate the 16-month-old boy with absent pointing.

Identified the lack of pointing to share interest as a profound deficit in joint attention.

Failure to point by 15 months is a critical early marker for autism spectrum disorder, overriding his normal gross motor skills.

3

Assess the 24-month-old girl's growth trajectory.

Correlated her downward shift in length percentiles with her 10th percentile mid-parental target height.

Normal shifting to genetic target height typically occurs between 6 and 18 months of age and then stabilizes, unlike pathologic growth failure.

4

Analyze the 14-month-old boy's growth faltering.

Noted an asymmetric growth failure where weight dropped significantly while length was preserved.

Nutritional deficiency (inadequate caloric intake) classically affects weight first, then length, then head circumference.

5

Evaluate the 7-year-old girl with early breast development.

Synthesized the presence of thelarche with the normal bone age to rule out central precocious puberty.

Isolated premature thelarche is a benign condition characterized by a normal bone age; advanced bone age would indicate a pathologic precocious puberty.

Anahtar Kavram

Mastery of pediatric development requires distinguishing normal variants (shifting to genetic potential, isolated thelarche) from pathologic states (caloric malnutrition, precocious puberty, autism spectrum disorders) while strictly adjusting for prematurity.

Soru 511Soru →

Match each of the following highly specific autoantibodies to the rheumatologic condition with which they are most classically associated.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Cevabı ve açıklamayı göster

Cevap

Anti-dsDNA matches with Systemic Lupus Erythematosus; Anti-centromere matches with Limited Cutaneous Systemic Sclerosis; Anti-CCP matches with Rheumatoid Arthritis; Anti-Ro/SSA matches with Sjögren Syndrome.

Each listed autoantibody serves as a highly specific diagnostic marker for a classic rheumatologic condition. Anti-dsDNA confirms SLE. Anti-centromere confirms Limited Cutaneous Systemic Sclerosis. Anti-CCP confirms Rheumatoid Arthritis. Anti-Ro/SSA strongly supports a diagnosis of Sjögren Syndrome.

Adım Adım Çözüm

1

Evaluate the clinical association for Anti-dsDNA.

Anti-dsDNA is specific for Systemic Lupus Erythematosus.

This is a core diagnostic criterion for SLE that also helps monitor disease flares.

2

Evaluate the clinical association for Anti-centromere.

Anti-centromere is specific for Limited Cutaneous Systemic Sclerosis.

It distinguishes limited cutaneous disease from diffuse cutaneous systemic sclerosis, which is typically associated with anti-Scl-70.

3

Evaluate the clinical association for Anti-CCP.

Anti-CCP is specific for Rheumatoid Arthritis.

It is more specific than Rheumatoid Factor (RF) and serves as a strong prognostic marker for erosive disease.

4

Evaluate the clinical association for Anti-Ro/SSA.

Anti-Ro/SSA is specific for Sjögren Syndrome.

These antibodies are the primary serologic markers used to support a diagnosis of primary Sjögren Syndrome.

Anahtar Kavram

Autoantibody specificities in rheumatologic diseases

Soru 512Soru →

Match each classic peripheral blood smear or bone marrow finding to its most likely associated hematologic diagnosis.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Cevabı ve açıklamayı göster

Cevap

Auer rods indicate Acute myeloid leukemia; Smudge cells indicate Chronic lymphocytic leukemia; Howell-Jolly bodies indicate Sickle cell disease; Bite cells and Heinz bodies indicate Glucose-6-phosphate dehydrogenase deficiency.

Each peripheral smear finding is a classic hallmark of its respective disease process, reflecting the underlying pathophysiology such as cell fragility, absent splenic pitting, or specific intracellular inclusions.

Adım Adım Çözüm

1

Identify the lineage and pathogenesis associated with Auer rods.

Auer rods are pathognomonic for myeloblasts.

They consist of fused primary granules seen in acute myeloid leukemia.

2

Determine the origin of smudge cells on a peripheral smear.

Smudge cells represent fragile neoplastic lymphocytes.

This extreme fragility is a classic hallmark of chronic lymphocytic leukemia.

3

Recall the physiologic mechanism of splenic pitting regarding red blood cell inclusions.

The spleen removes nuclear remnants known as Howell-Jolly bodies.

Sickle cell disease leads to autoinfarction and functional asplenia, allowing these bodies to remain in circulation.

4

Correlate bite cells and Heinz bodies with their underlying metabolic defect.

These inclusions occur due to oxidative damage to hemoglobin.

Glucose-6-phosphate dehydrogenase deficiency impairs the red blood cell's ability to resist oxidative stress.

Anahtar Kavram

Classic pathognomonic findings on peripheral blood smears are essential for identifying specific hematologic malignancies and red blood cell disorders.

Soru 513Soru →

Match each atypical clinical presentation of a complex hematologic or coagulopathic disorder to the most appropriate and highly specific targeted management strategy.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Cevabı ve açıklamayı göster

Cevap

The correct matches align each pathophysiologic crisis with its targeted intervention: Acquired Hemophilia A requires bypassing agents; HIT requires a direct thrombin inhibitor; TTP requires plasma exchange; Obstetric APS without prior thrombosis requires prophylactic LMWH and aspirin; Warfarin necrosis requires Vitamin K reversal and heparin.

Each clinical scenario describes a specific, high-acuity hematologic disorder with a definitive, pathophysiology-driven treatment. Acquired Hemophilia A requires bypassing agents because autoantibodies neutralize standard factor replacement. HIT requires a non-heparin anticoagulant because any heparin fuels the immune response. TTP requires plasma exchange to remove ADAMTS13 autoantibodies. Obstetric APS requires prophylactic anticoagulation to prevent placental thrombosis. Warfarin necrosis requires immediate reversal of the vitamin K antagonist and therapeutic heparinization.

Adım Adım Çözüm

1

Analyze the first scenario featuring isolated prolonged aPTT that does not correct with a mixing study in an older adult with sudden bleeding.

Diagnosis is Acquired Hemophilia A (Factor VIII inhibitor).

The mixing study failure confirms an autoantibody inhibitor rather than a factor deficiency. Treatment requires bypassing the intrinsic pathway using rFVIIa.

2

Analyze the second scenario featuring heparin exposure, a greater than 50% platelet drop, and a necrotic skin lesion.

Diagnosis is Heparin-Induced Thrombocytopenia (HIT).

Antibodies to PF4-heparin complexes cause widespread platelet activation. Heparin must be stopped and a direct thrombin inhibitor started to prevent further thrombosis.

3

Analyze the third scenario featuring fever, confusion, severe thrombocytopenia, MAHA, and a normal coagulation panel.

Diagnosis is Thrombotic Thrombocytopenic Purpura (TTP).

ADAMTS13 deficiency leads to uncleaved von Willebrand factor multimers and microthrombi. Plasma exchange removes the offending autoantibody and replaces ADAMTS13.

4

Analyze the fourth scenario featuring a pregnant patient with recurrent miscarriages, positive antiphospholipid antibodies, and no history of DVT.

Diagnosis is obstetric Antiphospholipid Syndrome (APS).

In the absence of a prior unprovoked thrombosis, the evidence-based treatment to prevent fetal loss is prophylactic-dose LMWH and low-dose aspirin.

5

Analyze the fifth scenario featuring warfarin monotherapy initiation followed rapidly by skin necrosis.

Diagnosis is Warfarin-induced skin necrosis.

The rapid depletion of Protein C relative to procoagulant factors causes microvascular thrombosis. This emergency requires immediate warfarin reversal and administration of heparin.

Anahtar Kavram

Management of life-threatening hematologic and coagulopathic emergencies requires precise identification of the underlying pathophysiology (e.g., autoantibody inhibitor vs. enzyme deficiency) to select the correct targeted therapy.

Soru 514Soru →

Match each patient's clinical presentation and laboratory findings of hyponatremia with the most appropriate targeted initial therapeutic intervention.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Cevabı ve açıklamayı göster

Cevap

Proper therapy requires matching severe neurological symptoms to immediate hypertonic saline administration, and matching the remaining asymptomatic cases to targeted fluid management based on volume status (hypovolemic requires normal saline, euvolemic requires fluid restriction, and hypervolemic requires diuresis).

Matching the correct fluid therapy requires first ruling out severe symptoms (which necessitate hypertonic saline to prevent herniation) and then assessing volume status. Hypovolemic patients have total body sodium and water depletion, requiring isotonic saline volume expansion to shut off non-osmotic ADH. Euvolemic patients (often SIADH) have excess free water, which is treated with fluid restriction. Hypervolemic patients have profound sodium avidity but even greater water retention, treated effectively with loop diuretics.

Adım Adım Çözüm

1

Assess the severity of neurological symptoms in each clinical vignette.

The 78-year-old woman has severe symptoms (seizures) and requires immediate hypertonic (3%) saline to reverse cerebral edema.

Symptomatic severe hyponatremia is a neurological emergency that overrides the standard volume status-based algorithm.

2

Evaluate the clinical volume status of the remaining mildly symptomatic or asymptomatic patients.

The 42-year-old woman is hypovolemic (hypotensive, tachycardic). The 66-year-old man is hypervolemic (JVD, crackles). The 54-year-old man is euvolemic (normal turgor, moist mucous membranes).

In the absence of severe symptoms, the underlying volume status dictates the pathophysiology of ADH release and the targeted intervention.

3

Assign the appropriate therapeutic intervention to each distinct volume state.

Hypovolemia requires isotonic (0.9%) saline to restore perfusion. Hypervolemia requires diuresis (furosemide). Euvolemia (SIADH) requires fluid restriction.

Directly addressing the physiological trigger for ADH secretion (or restricting free water intake when ADH is inappropriately secreted) safely normalizes the serum sodium over time.

Anahtar Kavram

Management of hyponatremia is strictly determined by two main factors: the presence of severe neurological symptoms (requiring immediate 3% hypertonic saline) and the patient's clinical volume status.

Soru 515Soru →

Match the following common outpatient clinical presentations to their most appropriate first-line oral pharmacological therapy.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Cevabı ve açıklamayı göster

Cevap

Uncomplicated cystitis matches with nitrofurantoin. The purulent skin abscess matches with trimethoprim-sulfamethoxazole. Streptococcal pharyngitis matches with amoxicillin. Early localized Lyme disease matches with doxycycline.

Each clinical presentation aligns perfectly with a specific first-line antibiotic based on primary care guidelines. Nitrofurantoin treats uncomplicated cystitis effectively. Trimethoprim-sulfamethoxazole is appropriately used for CA-MRSA in purulent abscesses. Amoxicillin successfully treats Group A strep pharyngitis. Doxycycline is the gold standard for early localized Lyme disease.

Adım Adım Çözüm

1

Identify the underlying infectious diagnosis for each clinical vignette.

The presentations correspond to uncomplicated cystitis, purulent skin abscess (suspected MRSA), streptococcal pharyngitis, and early localized Lyme disease.

Accurate clinical diagnosis is required before selecting empirical antimicrobial therapy.

2

Assign the first-line oral antimicrobial agent for each identified condition based on standard guidelines.

Nitrofurantoin is assigned to cystitis, trimethoprim-sulfamethoxazole to the abscess, amoxicillin to pharyngitis, and doxycycline to Lyme disease.

Following evidence-based guidelines ensures optimal patient outcomes and promotes antibiotic stewardship.

Anahtar Kavram

First-line empiric antimicrobial therapy for common outpatient infections

Soru 516Soru →

Evaluate the following clinical presentations of immunocompromised patients with opportunistic infections. Match each clinical scenario with the most appropriate initial targeted pharmacotherapy.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Cevabı ve açıklamayı göster

Cevap

The correct matches require correlating the clinical and pathologic description with the pathogen: Pneumocystis jirovecii in a G6PD-deficient patient requires intravenous pentamidine; Tuberculous meningitis requires RIPE plus dexamethasone; Invasive aspergillosis requires intravenous voriconazole; Severe disseminated histoplasmosis requires liposomal amphotericin B; and Central nervous system nocardiosis requires high-dose trimethoprim-sulfamethoxazole.

Each pair correctly matches a specific opportunistic pathogen, identified by definitive clinical and diagnostic findings, with its first-line evidence-based pharmacotherapy, specifically taking into account critical patient-level constraints such as immune status, infection severity, and genetic enzyme deficiencies.

Adım Adım Çözüm

1

Identify the causal opportunistic pathogen for each clinical scenario based on pathognomonic historical, radiographic, and pathologic clues.

Scenario 1: Pneumocystis jirovecii. Scenario 2: Mycobacterium tuberculosis. Scenario 3: Aspergillus fumigatus. Scenario 4: Histoplasma capsulatum. Scenario 5: Nocardia species.

Accurate pathogen identification is the prerequisite for selecting targeted antimicrobial therapy.

2

Determine the standard first-line targeted therapy for each identified pathogen, modifying the choice based on strict patient-specific contraindications or required adjunctive therapies.

PCP standard therapy (TMP-SMX) is contraindicated by G6PD deficiency, necessitating IV pentamidine. TB meningitis strictly requires adjunctive corticosteroids alongside RIPE therapy to prevent fatal inflammation.

Rote memorization of first-line agents fails in complex clinical scenarios where host factors (e.g., enzyme deficiencies, critical CNS inflammation) dictate life-saving modifications to the standard regimen.

Anahtar Kavram

Diagnosis and targeted pharmacotherapy of complex opportunistic infections in immunocompromised hosts, requiring strict adherence to patient-specific contraindications.

Tahmini Süre:3m 0s

Soru 517Soru →

Match the following complex nephrologic and acid-base clinical presentations with their most appropriate specific therapeutic interventions.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Cevabı ve açıklamayı göster

Cevap

The correct pairings match gastrointestinal losses to oral potassium and alkali replacement; Type 1 RTA to alkali therapy; Type 4 RTA to loop diuretics or fludrocortisone; refractory heart failure hyponatremia to vaptans; and symptomatic severe SIADH to 3% hypertonic saline.

The correct matches appropriately pair the underlying pathophysiology of distinct nephrologic and acid-base disturbances with their specific targeted interventions. Identifying whether a non-anion gap metabolic acidosis is renal or gastrointestinal in origin relies on the Urine Anion Gap (

\text{UAG} = Na^+ + K^+ - Cl^-

). The UAG estimates urinary ammonium (

NH_4^+

) excretion. A negative UAG points to extrarenal GI losses requiring oral replacement. A positive UAG with hypokalemia and a urine pH

> 5.5

indicates Type 1 RTA, treated with alkali. A positive UAG with hyperkalemia indicates Type 4 RTA, treated by lowering potassium. For hyponatremia, refractory hypervolemic cases in heart failure are an indication for vaptans, whereas severe symptomatic cases (e.g., seizures) always require immediate

3\%

hypertonic saline.

Adım Adım Çözüm

1

Analyze the acid-base parameters and urine anion gap (UAG) for the first three patients.

Patient 1 has a negative UAG (GI loss). Patient 2 has a positive UAG, hypokalemia, and urine pH > 5.5 (Type 1 RTA). Patient 3 has a positive UAG, hyperkalemia, and urine pH < 5.5 (Type 4 RTA).

UAG estimates urinary ammonium excretion; a negative UAG indicates an intact renal response (extrarenal cause), while a positive UAG indicates a renal acidification defect (RTA).

2

Select the appropriate targeted intervention for each acid-base disorder.

GI losses require oral replacement. Type 1 RTA requires alkali to correct the distal defect. Type 4 RTA requires potassium-lowering agents like fludrocortisone or loop diuretics.

Therapies must strictly target the specific pathophysiological defect causing the acidosis.

3

Evaluate the volume status and symptom severity for the patients with hyponatremia.

Patient 4 has refractory hypervolemic hyponatremia (heart failure). Patient 5 has euvolemic hyponatremia (SIADH) with severe neurologic symptoms (seizures).

Hyponatremia management is dictated first by symptom severity (seizures require 3% saline) and then by volume status.

4

Match the hyponatremia presentations to their interventions.

Patient 4 matches with vasopressin-2 receptor antagonists (tolvaptan). Patient 5 matches with immediate 3% hypertonic saline.

Vaptans promote aquaresis in volume-overloaded states, while hypertonic saline rapidly reverses life-threatening cerebral edema.

Anahtar Kavram

Differentiation of non-anion gap metabolic acidoses using the urine anion gap and serum potassium, alongside targeted management of euvolemic and hypervolemic hyponatremia based on symptom severity.

Tahmini Süre:2m 30s

Soru 518Soru →

Match each clinical presentation of systemic vasculitis with the most likely specific diagnosis.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Cevabı ve açıklamayı göster

Cevap

The presentations match as follows: The older adult with temporal pain and amaurosis fugax has Giant cell arteritis. The patient with hepatitis and mononeuritis multiplex has Polyarteritis nodosa. The patient with saddle-nose deformity and pulmonary-renal syndrome has Granulomatosis with polyangiitis. The young female with unequal arm pressures has Takayasu arteritis.

Each systemic vasculitis has a characteristic clinical phenotype based on the size of the vessels involved and the specific organs targeted. Giant cell arteritis affects large branches of the carotid, causing vision changes and jaw/temporal pain in older adults. Polyarteritis nodosa is a medium-vessel disease associated with Hepatitis B that causes ischemia in mesenteric and peripheral nerve beds. Granulomatosis with polyangiitis is a small-vessel disease producing a triad of upper respiratory, lower respiratory, and renal symptoms. Takayasu arteritis is a large-vessel disease that causes granulomatous thickening of the aortic arch, leading to diminished pulses in young females.

Adım Adım Çözüm

1

Analyze the first presentation involving temporal pain, proximal muscle aching (polymyalgia rheumatica), and amaurosis fugax.

These findings are highly specific for large-vessel vasculitis involving branches of the carotid artery, commonly seen in adults over the age of 50.

Identifying the affected vessel size and patient demographic isolates Giant cell arteritis.

2

Evaluate the second vignette featuring a hepatitis infection, abdominal angina, and mononeuritis multiplex.

This points to a medium-vessel vasculitis that spares the pulmonary circulation and is strongly associated with Hepatitis B virus.

Recognizing disease associations and the specific ischemic beds confirms Polyarteritis nodosa.

3

Assess the third scenario with upper respiratory tract involvement, lower respiratory tract involvement, and renal failure.

This classic triad of necrotizing granulomatous inflammation indicates a specific small-vessel vasculitis.

The combination of ear/nose/throat, pulmonary, and renal manifestations is pathognomonic for Granulomatosis with polyangiitis.

4

Examine the final presentation of a young female with upper extremity claudication and asymmetric blood pressures.

This indicates a large-vessel vasculitis primarily affecting the aorta and its main branches, leading to stenosis.

Demographics and clinical signs of aortic arch branch stenosis define Takayasu arteritis.

Anahtar Kavram

Clinical presentation and vessel-size classification of systemic vasculitides

Soru 519Soru →

Review the clinical vignettes describing five different patients presenting with hematologic abnormalities. Based on the provided clinical presentations and laboratory profiles, which peripheral blood smear finding best matches each patient?

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Cevabı ve açıklamayı göster

Cevap

Patient 1 (SLE, hemolysis) matches with Spherocytes and polychromasia. Patient 2 (Mechanical valve, hemolysis) matches with Schistocytes and helmet cells. Patient 3 (Elderly, macrocytosis, normal vitamins) matches with Hyposegmented, hypogranular neutrophils. Patient 4 (Splenomegaly, dry tap) matches with Teardrop cells (dacrocytes) and nucleated red blood cells. Patient 5 (Alcoholism, neuropathy, macrocytosis) matches with Hypersegmented neutrophils and macro-ovalocytes.

The correct matches pair distinct clinical syndromes with their pathognomonic peripheral blood smear findings. Extravascular hemolysis in autoimmune disease produces spherocytes. Intravascular mechanical shear stress produces schistocytes. Bone marrow dysplasia (MDS) leads to hyposegmented neutrophils. Marrow fibrosis produces teardrop cells. Finally, impaired DNA synthesis from vitamin B12 deficiency leads to hypersegmented neutrophils.

Adım Adım Çözüm

1

Analyze the etiology of anemia in the 32-year-old woman with SLE.

The patient has warm autoimmune hemolytic anemia, matching with spherocytes and polychromasia.

SLE predisposes to IgG-mediated hemolysis, causing splenic macrophages to bite off portions of the RBC membrane, forming spherocytes without central pallor.

2

Identify the cause of hemolysis in the 68-year-old man with a mechanical valve.

The patient has macroangiopathic hemolytic anemia, matching with schistocytes.

Mechanical shearing of RBCs by the artificial valve leads to intravascular hemolysis and the formation of schistocytes. Normal platelets differentiate this from microangiopathic processes like TTP.

3

Evaluate the 72-year-old man with macrocytic anemia and normal vitamin levels.

The patient most likely has a myelodysplastic syndrome (MDS), matching with hyposegmented, hypogranular neutrophils.

MDS frequently presents in elderly patients with macrocytic anemia. The smear classically shows dysplastic features such as the pseudo-Pelger-Huet anomaly.

4

Assess the 64-year-old man with massive splenomegaly and a 'dry tap'.

The clinical picture indicates primary myelofibrosis, matching with teardrop cells.

Bone marrow fibrosis results in a dry tap and extramedullary hematopoiesis in the spleen. This process forces RBCs through fibrotic marrow, producing teardrop cells.

5

Diagnose the 45-year-old man with macrocytosis and neurologic deficits.

The patient has a megaloblastic anemia due to vitamin B12 deficiency, matching with hypersegmented neutrophils.

Neurologic symptoms paired with an elevated MCV point to B12 deficiency, which impairs DNA synthesis and produces hypersegmented neutrophils (≥5 lobes) and macro-ovalocytes.

Anahtar Kavram

Correlation of distinct anemia etiologies and bone marrow disorders with their characteristic peripheral blood smear morphologies.

Tahmini Süre:1m 30s

Soru 520Soru →

Targeted biologic and synthetic disease-modifying antirheumatic drugs (DMARDs) have revolutionized the management of rheumatologic conditions, but they carry risks for unique and severe adverse effects. Match each clinical vignette describing a therapy-related complication with the specific medication class most likely responsible.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Cevabı ve açıklamayı göster

Cevap

The correct mappings are:
1. The patient with new-onset heart failure matches with TNF-alpha inhibitors.
2. The patient with Progressive Multifocal Leukoencephalopathy (PML) matches with Anti-CD20 monoclonal antibodies.
3. The patient with G6PD-associated hemolytic anemia matches with Recombinant uricase.
4. The patient with Herpes zoster reactivation matches with Janus kinase (JAK) inhibitors.

Each advanced rheumatologic medication class operates via distinct pathophysiologic mechanisms that lead to highly specific toxicities. TNF-alpha inhibitors depress myocardial function. Anti-CD20 agents deplete B-cells allowing opportunistic JC virus reactivation. Recombinant uricase generates oxidative stress, unmasking G6PD deficiency. JAK inhibitors impair antiviral signaling, predisposing specifically to VZV reactivation.

Adım Adım Çözüm

1

Analyze the first vignette describing new-onset systolic heart failure following biologic initiation.

Identify TNF-alpha inhibitors as the responsible class.

TNF-alpha inhibition can paradoxically depress myocardial function and worsen or induce heart failure in susceptible individuals.

2

Evaluate the second vignette detailing subacute cognitive decline and focal neurologic deficits with non-enhancing white matter lesions.

Identify this as Progressive Multifocal Leukoencephalopathy (PML) linked to Anti-CD20 monoclonal antibodies.

Rituximab profoundly depletes B-cells, impairing the immune surveillance required to keep the JC virus latent, leading to central nervous system demyelination.

3

Assess the third vignette describing oxidative hemolysis (bite cells, Heinz bodies) after gout treatment.

Identify Recombinant uricase (pegloticase) as the trigger.

Pegloticase generates hydrogen peroxide. In individuals with G6PD deficiency (common in Mediterranean descent), this overwhelms antioxidant defenses, causing hemolysis.

4

Examine the fourth vignette depicting dermatomal varicella-zoster virus reactivation.

Identify Janus kinase (JAK) inhibitors as the cause.

JAK-STAT pathway inhibition strongly suppresses interferon-mediated antiviral responses, making Herpes zoster a hallmark toxicity of this drug class.

Anahtar Kavram

Severe and unique adverse effect profiles of targeted DMARDs and biologic therapies in rheumatology.

Tahmini Süre:2m 0s

Cevap

Adım Adım Çözüm

Anahtar Kavram

Sık Yapılan Hatalar

Cevap

Adım Adım Çözüm

Anahtar Kavram

Sık Yapılan Hatalar

Cevap

Adım Adım Çözüm

Anahtar Kavram

Sık Yapılan Hatalar

Cevap

Adım Adım Çözüm

Anahtar Kavram

Sık Yapılan Hatalar

Cevap

Adım Adım Çözüm

Anahtar Kavram

Sık Yapılan Hatalar

Cevap

Adım Adım Çözüm

Anahtar Kavram

Sık Yapılan Hatalar

Cevap

Adım Adım Çözüm

Anahtar Kavram

Sık Yapılan Hatalar

Cevap

Adım Adım Çözüm

Anahtar Kavram

Sık Yapılan Hatalar

Cevap

Adım Adım Çözüm

Anahtar Kavram

Sık Yapılan Hatalar

Cevap

Adım Adım Çözüm

Anahtar Kavram

Sık Yapılan Hatalar

Cevap

Adım Adım Çözüm

Anahtar Kavram

Sık Yapılan Hatalar

Cevap

Adım Adım Çözüm

Anahtar Kavram

Sık Yapılan Hatalar

Cevap

Adım Adım Çözüm

Anahtar Kavram

Sık Yapılan Hatalar

Cevap

Adım Adım Çözüm

Anahtar Kavram

Sık Yapılan Hatalar

Cevap

Adım Adım Çözüm

Anahtar Kavram

Sık Yapılan Hatalar

Cevap

Adım Adım Çözüm

Anahtar Kavram

Sık Yapılan Hatalar

Cevap

Adım Adım Çözüm

Anahtar Kavram

Sık Yapılan Hatalar

Cevap

Adım Adım Çözüm

Anahtar Kavram

Sık Yapılan Hatalar

Cevap

Adım Adım Çözüm

Anahtar Kavram

Sık Yapılan Hatalar

Cevap

Adım Adım Çözüm

Anahtar Kavram